Inventor
DEDHIYA MAHENDRA G
US22 patents
⚠️ This page may combine multiple inventors who share the name “DEDHIYA MAHENDRA G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RICHTER GEDEON NYRT
5 patentsUSRE47350EApr 16, 2019
Pharmaceutical formulations containing dopamine receptor ligands
RICHTER GEDEON NYRT4 citations82
USRE47333EApr 2, 2019
Pharmaceutical formulations containing dopamine receptor ligands
RICHTER GEDEON NYRT4 citations82
US9056846B2Jun 16, 2015
Pharmaceutical formulations containing dopamine receptor ligands
RICHTER GEDEON NYRT4 citations82
USRE49110EJun 21, 2022
Pharmaceutical formulations containing dopamine receptor ligands
RICHTER GEDEON NYRT1 citations71
USRE49302ENov 15, 2022
Pharmaceutical formulations containing dopamine receptor ligands
RICHTER GEDEON NYRT0 citations60
FOREST LAB HOLDINGS LTD
4 patentsUS8039009B2Oct 18, 2011
Modified release formulations of memantine oral dosage forms
FOREST LAB HOLDINGS LTD61 citations92
US9062053B2Jun 23, 2015
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-Diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
FOREST LAB HOLDINGS LTD15 citations89
US8835455B2Sep 16, 2014
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
FOREST LAB HOLDINGS LTD15 citations89
US9259403B2Feb 16, 2016
Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide
FOREST LAB HOLDINGS LTD0 citations51
RONSHEIM MELANIE SIMONE
3 patentsUS9284314B2Mar 15, 2016
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
RONSHEIM MELANIE SIMONE15 citations89
US8969566B2Mar 3, 2015
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
RONSHEIM MELANIE SIMONE17 citations89
US8829191B2Sep 9, 2014
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
RONSHEIM MELANIE SIMONE18 citations89
DEDHIYA MAHENDRA G
3 patentsUS8471025B2Jun 25, 2013
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
DEDHIYA MAHENDRA G26 citations87
US8865937B2Oct 21, 2014
Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide
DEDHIYA MAHENDRA G0 citations49
US8247400B2Aug 21, 2012
Cephem compounds useful for the treatment of bacterial infections
DEDHIYA MAHENDRA G0 citations31
FOREST LABORATORIES HOLDINGS LTD
3 patentsUS9695122B2Jul 4, 2017
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
FOREST LABORATORIES HOLDINGS LTD0 citations48
US9580424B2Feb 28, 2017
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
FOREST LABORATORIES HOLDINGS LTD0 citations47
US10660868B2May 26, 2020
Modified release formulations of memantine oral dosage forms
FOREST LABORATORIES HOLDINGS LTD0 citations45